GEMITIDE INJ

GEMITIDE Injection contains Methoxy Polyethylene Glycol-Epoetin Beta, a long-acting erythropoiesis-stimulating agent (ESA) used to treat anemia associated with chronic kidney disease (CKD). It works by stimulating the bone marrow to produce more red blood cells, helping improve hemoglobin levels and reduce symptoms such as fatigue, weakness, and shortness of breath.

GEMITIDE is commonly prescribed for patients undergoing dialysis or suffering from kidney-related anemia, providing sustained stimulation of red blood cell production with less frequent dosing compared to conventional erythropoietin therapies.